Ola, I., Talala, K., Tammela, T., Taari, K., Murtola, T. J., Kujala, P., . . . Auvinen, A. (2025). Long-term risk of prostate cancer mortality among men with baseline prostate-specific antigen below 3 ng/ml: Evidence from the finnish randomized study of screening for prostate cancer. European urology oncology, 8(2), . https://doi.org/10.1016/j.euo.2024.11.010
Chicago-Zitierstil (17. Ausg.)Ola, Idris, Kirsi Talala, Teuvo Tammela, Kimmo Taari, Teemu J. Murtola, Paula Kujala, Jani Raitanen, und Anssi Auvinen. "Long-term Risk of Prostate Cancer Mortality Among Men with Baseline Prostate-specific Antigen Below 3 Ng/ml: Evidence from the Finnish Randomized Study of Screening for Prostate Cancer." European Urology Oncology 8, no. 2 (2025). https://doi.org/10.1016/j.euo.2024.11.010.
MLA-Zitierstil (9. Ausg.)Ola, Idris, et al. "Long-term Risk of Prostate Cancer Mortality Among Men with Baseline Prostate-specific Antigen Below 3 Ng/ml: Evidence from the Finnish Randomized Study of Screening for Prostate Cancer." European Urology Oncology, vol. 8, no. 2, 2025, https://doi.org/10.1016/j.euo.2024.11.010.